The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells
Open accessAbstract
OBJECTIVE Prosthetic and bioprosthetic materials currently in use lack growth potential and therefore must be repeatedly replaced in pediatric patients as they grow. Tissue engineering is a new discipline that offers the potential for creating replacement structures from autologous cells and biodegradable polymer scaffolds. In May 2000, we initiated clinical application of tissue-engineered vascular grafts seeded with cultured cells. However, cell culturing is time-consuming, and xenoserum must be used. To overcome these disadvantages, we began to use bone marrow cells, readily available on the day of surgery, as a cell source. The aim of the study was to assess the safety and feasibility of this technique for creating vascular tissue under low-pressure systems such as pulmonary artery or venous pressure. METHODS Since September 2001, tissue-engineered grafts seeded with autologous bone marrow cells have been implanted in 42 patients. The patients or their parents were fully informed and had given consent to the procedure. A 5-mL/kg specimen of bone marrow was aspirated with the patient under general anesthesia before the skin incision. The polymer tube serving as a scaffold for the cells was composed of a copolymer of l -lactide and -caprolactone (50:50). This copolymer is degraded by hydrolysis. The matrix is more than 80% porous, and the diameter of each pore is 20 to 100 microm. Polyglycolic acid woven fabric with a thickness of 0.5 mm was used for reinforcement. Twenty-three tissue-engineered conduits (grafts for extracardiac total cavopulmonary connection) and 19 tissue-engineered patches were used for the repair of congenital heart defects. The patients' ages ranged from 1 to 24 years (median 5.5 years). All patients underwent a catheterization study, computed tomographic scan, or both, for evaluation after the operation. The patients received anticoagulation therapy for 3 to 6 months after surgery. RESULTS Mean follow-up after surgery was 490 +/- 276 days (1.3-31.6 months, median 16.7 months). There were no complications such as thrombosis, stenosis, or obstruction of the tissue-engineered autografts. One late death at 3 months after total cavopulmonary connection was noted in patient with hypoplastic left heart syndrome; this was unrelated to the tissue-engineered graft function. There was no evidence of aneurysm formation or calcification on cineangiography or computed tomography. All tube grafts were patent, and the diameter of the tube graft increased with time (110% +/- 7 % of the implanted size). CONCLUSION Biodegradable conduits or patches seeded with autologous bone marrow cells showed normal function (good patency to a maximum follow-up of 32 months). As living tissues, these vascular structures may have the potential for growth, repair, and remodeling. The tissue-engineering approach may provide an important alternative to the use of prosthetic materials in the field of pediatric cardiovascular surgery. Longer follow-up is necessary to confirm the durability of this approach.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Langer, R., & Vacanti, J. P. (1993) · Science · doi:10.1126/science.8493529 · Cited by 9,893
Isolation of Putative Progenitor Endothelial Cells for Angiogenesis
Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., Witzenbichler, B., Schatteman, G., & Isner, J. M. (1997) · Science · doi:10.1126/science.275.5302.964 · Cited by 8,725
Asahara, T., Masuda, H., Takahashi, T., Kalka, C., Pastore, C., Silver, M., Kearne, M., Magner, M., & Isner, J. M. (1999) · Circulation Research · doi:10.1161/01.res.85.3.221 · Cited by 3,253
Takahashi, T., Kalka, C., Masuda, H., Chen, D., Silver, M., Kearney, M., Magner, M., Isner, J. M., & Asahara, T. (1999) · Nature Medicine · doi:10.1038/7434 · Cited by 2,423
Evidence for Circulating Bone Marrow-Derived Endothelial Cells
Shi, Q., Rafii, S., Wu, M. H.-D., Wijelath, E. S., Yu, C., Ishida, A., Fujita, Y., Kothari, S., Mohle, R., Sauvage, L. R., et al. (1998) · Blood · doi:10.1182/blood.v92.2.362 · Cited by 1,695
Mobilization of Endothelial Progenitor Cells in Patients With Acute Myocardial Infarction
Shintani, S., Murohara, T., Ikeda, H., Ueno, T., Honma, T., Katoh, A., Sasaki, K.-I., Shimada, T., Oike, Y., & Imaizumi, T. (2001) · Circulation · doi:10.1161/hc2301.092122 · Cited by 1,185
Eto, T., & Takahashi, H. (1999) · Nature Medicine · doi:10.1038/8462 · Cited by 915
Transplantation of a Tissue-Engineered Pulmonary Artery
Shin'oka, T., Imai, Y., & Ikada, Y. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102153440717 · Cited by 634
Self-citationTissue engineering heart valves: Valve leaflet replacement study in a lamb model
Shinoka, T., Breuer, C. K., Tanel, R. E., Zund, G., Miura, T., Ma, P. X., Langer, R., Vacanti, J. P., & Mayer, J. E. (1995) · The Annals of Thoracic Surgery · doi:10.1016/0003-4975(95)00733-4 · Cited by 449
Self-citationCreation Of Viable Pulmonary Artery Autografts Through Tissue Engineering
Shinoka, T., Shum-Tim, D., Ma, P. X., Tanel, R. E., Isogai, N., Langer, R., Vacanti, J. P., & Mayer, J. E. (1998) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(98)70315-0 · Cited by 444
Self-citationSuccessful application of tissue engineered vascular autografts: clinical experience
Matsumura, G., Hibino, N., Ikada, Y., Kurosawa, H., & Shin’oka, T. (2003) · Biomaterials · doi:10.1016/s0142-9612(03)00043-7 · Cited by 276
Self-citationMatsumura, G., Miyagawa-Tomita, S., Shin’oka, T., Ikada, Y., & Kurosawa, H. (2003) · Circulation · doi:10.1161/01.cir.0000092165.32213.61 · Cited by 275
Self-citationBhattacharya, V., McSweeney, P. A., Shi, Q., Bruno, B., Ishida, A., Nash, R., Storb, R. F., Sauvage, L. R., Hammond, W. P., & Wu, M. H.-D. (2000) · Blood · doi:10.1182/blood.v95.2.581 · Cited by 271
McKay, R. (2000) · Nature · doi:10.1038/35019186 · Cited by 249
Tissue-engineered heart valves. Autologous valve leaflet replacement study in a lamb model.
Shinoka, T., Ma, P. X., Shum‐Tim, D., Breuer, C. K., Cusick, R. A., Zünd, G., Langer, R., Vacanti, J. P., & Mayer, J. E. (1996) · PubMed · Cited by 246
Self-citationTissue-Engineered Vascular Autograft: Inferior Vena Cava Replacement in a Dog Model
Watanabe, M., Shin'oka, T., Tohyama, S., Hibino, N., Konuma, T., Matsumura, G., Kosaka, Y., Ishida, T., Imai, Y., Yamakawa, M., et al. (2001) · Tissue Engineering · doi:10.1089/10763270152436481 · Cited by 215
Self-citationFluorimetric DNA assay for cell growth estimation
Rao, J., & Otto, W. R. (1992) · Analytical Biochemistry · doi:10.1016/0003-2697(92)90521-8 · Cited by 196
Autocrine angiogenic vascular prosthesis with bone marrow transplantation
Noishiki, Y., Tomizawa, Y., YAMANE, Y., & Matsumoto, A. (1996) · Nature Medicine · doi:10.1038/nm0196-90 · Cited by 155
Tissue engineering lamb heart valve leaflets
Breuer, C. K., Shinoka, T., Tanel, R. E., Zünd, G., Mooney, D. J., Ma, P. X., Miura, T., Colan, S. D., Langer, R., Mayer, J. E., et al. (1996) · Biotechnology and Bioengineering · doi:10.1002/(sici)1097-0290(19960605)50:5<562::aid-bit11>3.0.co;2-l · Cited by 87
Self-citationTissue engineering of cardiovascular structures
Mayer, J. E., Shinoka, T., & Shum‐Tim, D. (1997) · Current Opinion in Cardiology · doi:10.1097/00001573-199711000-00005 · Cited by 81
Self-citationWeissenstein, C., Human, P., Bezuidenhout, D., & Zilla, P. (2000) · PubMed · Cited by 46
Cited by
Inspiration and application in the evolution of biomaterials
Huebsch, N., & Mooney, D. J. (2009) · Nature · doi:10.1038/nature08601 · Cited by 855
The Tissue-Engineered Vascular Graft—Past, Present, and Future
Pashneh-Tala, S., MacNeil, S., & Claeyssens, F. (2016) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2015.0100 · Cited by 798
Konig, G., McAllister, T. N., Dusserre, N., Garrido, S. A., Iyican, C., Marini, A., Fiorillo, A., Avila, H., Wystrychowski, W., Zagalski, K., et al. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2008.11.011 · Cited by 582
Readily Available Tissue-Engineered Vascular Grafts
Dahl, S. L. M., Kypson, A. P., Lawson, J. H., Blum, J. L., Strader, J. T., Li, Y., Manson, R. J., Tente, W. E., DiBernardo, L., Hensley, M. T., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001426 · Cited by 563
Roh, J. D., Sawh-Martinez, R., Brennan, M. P., Jay, S. M., Devine, L., Rao, D. A., Yi, T., Mirensky, T. L., Nalbandian, A., Udelsman, B., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911465107 · Cited by 559
Self-citation
Metadata
- Authors
- Shin’oka, T., Matsumura, G., Hibino, N., Naito, Y., Watanabe, M., Konuma, T., Sakamoto, T., Nagatsu, M., & Kurosawa, H.
- Venue
- The Journal of Thoracic and Cardiovascular Surgery
- Publisher
- Elsevier BV
- Published
- 2005-06
- Volume
- 129
- Issue
- 6
- Pages
- 1330-1338
- ISSN
- 0022-5223 (ISSN-L)
- OpenAlex
- W2073889644
- Cited by
- 585
- References
- 21
- FWCI
- 23.53
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.